Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial
A Mujugira, AS Magaret, C Celum… - The Journal of …, 2013 - academic.oup.com
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial
A Mujugira, AS Magaret, C Celum, JM Baeten… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
[引用][C] Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial
A MUJUGIRA, AS MAGARET, E KARITA… - The Journal of …, 2013 - pascal-francis.inist.fr
Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1
Coinfected Persons: A Randomized Controlled Trial CNRS Inist Pascal-Francis CNRS …
Coinfected Persons: A Randomized Controlled Trial CNRS Inist Pascal-Francis CNRS …
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
A Mujugira, AS Magaret, C Celum… - The Journal of …, 2013 - researchonline.lshtm.ac.uk
BACKGROUND: Daily suppressive therapy with valacyclovir reduces risk of sexual
transmission of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual …
transmission of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual …
[PDF][PDF] Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial
A Mujugira, AS Magaret, C Celum… - The Journal of …, 2013 - researchgate.net
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
[HTML][HTML] Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial
A Mujugira, AS Magaret, C Celum… - The Journal of …, 2013 - ncbi.nlm.nih.gov
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
[PDF][PDF] Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial
A Mujugira, AS Magaret, C Celum, JM Baeten… - 2013 - Citeseer
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
A Mujugira, AS Magaret, C Celum, JM Baeten… - 2013 - cabidigitallibrary.org
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial.
A Mujugira, AS Magaret, C Celum, JM Baeten… - 2013 - erepository.uonbi.ac.ke
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
A Mujugira, AS Magaret, C Celum… - The Journal of …, 2013 - europepmc.org
Background Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2-serodiscordant heterosexual couples by …